RG1068 (Synthetic Human Secretin)
Phase 3Terminated 0 watching 0 views this week๐ Rising
74
Development Stage
โ
Pre-clinicalโ
Phase 1โ
Phase 24
Phase 35
ApprovedAbout RG1068 (Synthetic Human Secretin)
RG1068 (Synthetic Human Secretin) is a phase 3 stage product being developed by Repligen for Autism. The current trial status is terminated. This product is registered under clinical trial identifier NCT00036231. Target conditions include Autism.
Hype Score Breakdown
Clinical
27
Activity
18
Company
7
Novelty
9
Community
10
Clinical Trials (4)
| NCT ID | Phase | Status |
|---|---|---|
| NCT00660335 | Phase 3 | Completed |
| NCT00216294 | Phase 2 | Completed |
| NCT00036231 | Phase 3 | Terminated |
| NCT00036244 | Phase 3 | Completed |
Competing Products
20 competing products in Autism